best glp 1 drugs for weight loss How GLP-1 medications are transforming diabetes and treatment You might know them as

94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo

We have been waiting for this trial, says Leslie Cho, MD, Co-Section Head of Preventive Cardiology at Cleveland Clinic

When death from suicide and non-fatal self-harm were combined, GLP1 receptor agonists appear to be protective

Yi et al., 2024)

Villaschi A, Ferrante G, Cannata F, Pini D, Pagnesi M, Corrada E et al (2024) GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis